Literature DB >> 18029970

Triple-negative breast cancer: MRI features in 29 patients.

J-H Chen, G Agrawal, B Feig, H-M Baek, P M Carpenter, R S Mehta, O Nalcioglu, M-Y Su.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18029970     DOI： 10.1093/annonc/mdm504

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  23 in total

Review 1.  Triple-negative breast cancer: present challenges and new perspectives.

Authors:  Franca Podo; Lutgarde M C Buydens; Hadassa Degani; Riet Hilhorst; Edda Klipp; Ingrid S Gribbestad; Sabine Van Huffel; Hanneke W M van Laarhoven; Jan Luts; Daniel Monleon; Geert J Postma; Nicole Schneiderhan-Marra; Filippo Santoro; Hans Wouters; Hege G Russnes; Therese Sørlie; Elda Tagliabue; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

2.  Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?

Authors:  S Bahri; J-H Chen; H J Yu; A Kuzucan; O Nalcioglu; M-Y Su
Journal:  Ann Oncol       Date:  2008-03-05       Impact factor: 32.976

3.  Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.

Authors:  Zheng Han; Han Cheng; Jenny G Parvani; Zhuxian Zhou; Zheng-Rong Lu
Journal:  Magn Reson Med       Date:  2017-10-29       Impact factor: 4.668

4.  Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.

Authors:  Tianwen Xie; Qiufeng Zhao; Caixia Fu; Qianming Bai; Xiaoyan Zhou; Lihua Li; Robert Grimm; Li Liu; Yajia Gu; Weijun Peng
Journal:  Eur Radiol       Date:  2018-11-06       Impact factor: 5.315

5.  Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Authors:  Aida Kuzucan; Jeon-Hor Chen; Shadfar Bahri; Rita S Mehta; Philip M Carpenter; Peter T Fwu; Hon J Yu; David J B Hsiang; Karen T Lane; John A Butler; Stephen A Feig; Min-Ying Su
Journal:  Clin Breast Cancer       Date:  2012-04       Impact factor: 3.225

6.  Role of MRI in the staging of breast cancer patients: does histological type and molecular subtype matter?

Authors:  Almir G V Bitencourt; Nara P Pereira; Luciana K L França; Caroline B Silva; Jociana Paludo; Hugo L S Paiva; Luciana Graziano; Camila S Guatelli; Juliana A Souza; Elvira F Marques
Journal:  Br J Radiol       Date:  2015-09-16       Impact factor: 3.039

7.  Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers.

Authors:  Martine Boisserie-Lacroix; Gaëtan Macgrogan; Marc Debled; Stéphane Ferron; Maryam Asad-Syed; Pippa McKelvie-Sebileau; Simone Mathoulin-Pélissier; Véronique Brouste; Gabrielle Hurtevent-Labrot
Journal:  Oncologist       Date:  2013-07-02

8.  Vascular characterisation of triple negative breast carcinomas using dynamic MRI.

Authors:  Sonia P Li; Anwar R Padhani; N Jane Taylor; Mark J Beresford; Mei-Lin W Ah-See; J James Stirling; James A d'Arcy; David J Collins; Andreas Makris
Journal:  Eur Radiol       Date:  2011-01-22       Impact factor: 5.315

Review 9.  How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer.

Authors:  Elissa R Price; Jasmine Wong; Rita Mukhtar; Nola Hylton; Laura J Esserman
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

10.  Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.

Authors:  Shannon C Agner; Mark A Rosen; Sarah Englander; John E Tomaszewski; Michael D Feldman; Paul Zhang; Carolyn Mies; Mitchell D Schnall; Anant Madabhushi
Journal:  Radiology       Date:  2014-03-10       Impact factor: 11.105
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.